BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 17258588)

  • 1. Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
    Wan S; Shukla N; Yim AP; Johnson JL; Angelini GD; Jeremy JY
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):494-500. PubMed ID: 17258588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
    Wan S; Yim AP; Johnson JL; Shukla N; Angelini GD; Smith FC; Dashwood MR; Jeremy JY
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1317-22. PubMed ID: 15115988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1).
    Wan S; Shukla N; Angelini GD; Yim AP; Johnson JL; Jeremy JY
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1033-9. PubMed ID: 17903525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening.
    Jeremy JY; Bulbulia R; Johnson JL; Gadsdon P; Vijayan V; Shukla N; Smith FC; Angelini GD
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1766-72. PubMed ID: 15173735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts.
    Wan S; Arifi AA; Chan MC; Yip JH; Ng CS; Chow LT; Yim AP; Jeremy JY
    Eur J Cardiothorac Surg; 2006 May; 29(5):742-6; discussion 747. PubMed ID: 16581260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
    Vijayan V; Shukla N; Johnson JL; Gadsdon P; Angelini GD; Smith FC; Baird R; Jeremy JY
    J Vasc Surg; 2004 Nov; 40(5):1011-9. PubMed ID: 15557918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periadventitial rapamycin-eluting microbeads promote vein graft disease in long-term pig vein-into-artery interposition grafts.
    Rajathurai T; Rizvi SI; Lin H; Angelini GD; Newby AC; Murphy GJ
    Circ Cardiovasc Interv; 2010 Apr; 3(2):157-65. PubMed ID: 20332383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
    Ehsan A; Mann MJ; Dell'Acqua G; Dzau VJ
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):714-22. PubMed ID: 11279413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of osteopontin in the development of neointimal hyperplasia in vein grafts.
    Kang N; Ng CS; Hu J; Qiu ZB; Underwood MJ; Jeremy JY; Wan S
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1384-9. PubMed ID: 22219474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term effects of cytochalasin D, paclitaxel and rapamycin on wall thickening in experimental porcine vein grafts.
    Murphy GJ; Johnson TW; Chamberlain MH; Rizvi SI; Wyatt M; George SJ; Angelini GD; Karsch KR; Oberhoff M; Newby AC
    Cardiovasc Res; 2007 Feb; 73(3):607-17. PubMed ID: 17187765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bypass graft disease: analysis of proliferative activity in human aorto-coronary bypass grafts.
    Hilker M; Buerke M; Lehr HA; Oelert H; Hake U
    Heart Surg Forum; 2002; 5 Suppl 4():S331-41. PubMed ID: 12759206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-course of medial and intimal thickening in pig venous arterial grafts: relationship to endothelial injury and cholesterol accumulation.
    Angelini GD; Bryan AJ; Williams HM; Soyombo AA; Williams A; Tovey J; Newby AC
    J Thorac Cardiovasc Surg; 1992 Jun; 103(6):1093-103. PubMed ID: 1597973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of intimal proliferation after vein grafting by chitosan nanoparticle with proliferation cell nuclear antigen-antisense oligo deoxy nucleotides].
    Chen Z; Zhang H; Xia J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Dec; 21(12):1348-54. PubMed ID: 18277682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
    Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis.
    Lee BH; Nam HY; Kwon T; Kim SJ; Kwon GY; Jeon HJ; Lim HJ; Lee WK; Park JS; Ko JY; Kim DJ
    Nephrol Dial Transplant; 2006 Sep; 21(9):2432-8. PubMed ID: 16554328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of endothelin-1 (ET) receptors (ET(A) and ET(B)) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts.
    Dashwood MR; Mehta D; Izzat MB; Timm M; Bryan AJ; Angelini GD; Jeremy JY
    Atherosclerosis; 1998 Apr; 137(2):233-42. PubMed ID: 9622266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 MAPK inhibitor, CBS3830 limits vascular remodelling in arterialised vein grafts.
    Ge JJ; Zhao ZW; Zhou ZC; Wu S; Zhang R; Pan FM; Abendroth DK
    Heart Lung Circ; 2013 Sep; 22(9):751-8. PubMed ID: 23523564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties.
    Mekontso-Dessap A; Kirsch M; Guignambert C; Zadigue P; Adnot S; Loisance D; Eddahibi S
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):651-8. PubMed ID: 16515919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.